Post-traumatic Stress Disorder
📧 Sign up to get email alerts when something new happens for Post-traumatic Stress Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-01-25FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) filed by Roerig.
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD [NA]
Clinical trial completed evaluating mindfulness meditation for women with comorbid PTSD and substance use disorder; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Primary Care Brief Mindfulness Training for Veterans With PTSD [NA]
A completed clinical trial evaluating primary care brief mindfulness training for veterans with PTSD; results posted in 2022.
-
FDA approval · 2022-12-05FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA has approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, allowing the generic to be marketed as part o…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Trauma-informed Collaborative Care for Low-income African Americans With PTSD [NA]
Clinical trial update for trauma-informed collaborative care targeting PTSD in low-income African Americans; study completed with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Tools for Health and Resilience Implemented After Violence Exposure (Project THRIVE) [NA]
Clinical trial update for Project THRIVE investigating resilience tools after violence exposure; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Primary Care Treatment Integrating Motivation and Exposure [NA]
Clinical trial update for a primary care treatment integrating motivation and exposure addressing post-traumatic stress disorder and alcohol…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Physiological Augmentation of Mindfulness Meditation [NA]
A completed clinical trial from Emory University investigating physiological augmentation of mindfulness meditation for Post Traumatic Stres…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Zambia Common Elements Treatment Approach Pilot Study [NA]
A pilot study update for the Zambia Common Elements Treatment Approach was terminated; results posted in 2022, investigating treatment for c…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder [NA]
This completed Wayne State University trial investigated cannabinoids' influence on fear extinction neural circuits in post-traumatic stress…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study [Phase 4]
Phase 4 trial update examining the effects of Delta-9-tetrahydrocannabinol (THC) on retention of fear extinction learning in post-traumatic …
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Ketamine and Epigenetic Aging [Phase 2]
Phase 2 clinical trial update exploring ketamine and epigenetic aging for depression and PTSD.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder [Phase 4]
Phase 4 trial evaluating pimavanserin for insomnia in veterans with PTSD has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) [Phase 4]
Phase 4 trial update for tramadol extended-release in post-traumatic stress disorder has completed with posted results.
-
FDA approval · 2022-08-30FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride as a generic, confirming approval under the ANDA p…
-
FDA label_change · 2022-08-30FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for a sertraline hydrochloride generic from Quallent Pharmaceuticals Health LLC, updating the labeli…
-
CLINICAL_TRIALS research · 2022-08-23Clinical Trial Update: DDBT Adapted Problem Solving Treatment for Primary Care [NA]
Clinical trial update on adapted problem solving treatment for primary care showing completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Combined Ketamine and eCBT Intervention for PTSD [Phase 2]
Phase 2 clinical trial exploring a combined ketamine and eCBT intervention for post-traumatic stress disorder is in early stages with an unk…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Neuromodulation for Post-Traumatic Stress Disorder [NA]
Completed clinical trial evaluating neuromodulation for post-traumatic stress disorder; results posted in 2022.
-
CLINICAL_TRIALS withdrawal · 2022-06-03Clinical Trial Update: Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder [Phase 2, Phase 3]
A clinical trial studying nabiximols Oromucosal spray for PTSD has been withdrawn after Phase 2/3 development.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Comparison of Two Treatments for Post-Traumatic Stress Disorder [Phase 3]
Phase 3 trial comparing two treatments for post-traumatic stress disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder [Phase 2]
Phase 2 trial evaluating safety and efficacy of NYX-783 in adults with Post-Traumatic Stress Disorder has completed with results posted in 2…
-
CLINICAL_TRIALS research · 2022-04-22Clinical Trial Update: Reproductive Life Planning for Women With Mental Illness [NA]
Clinical trial update on reproductive life planning for women with mental illness; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Antidepressant Response in Older Adults With Comorbid PTSD and MDD [Phase 4]
Phase 4 trial assessing antidepressant response in older adults with comorbid PTSD and major depressive disorder has been terminated with re…